drugset / Trial / NCT07036861

A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension

NCT07036861

Phase 1 Completed 74 enrolled Berlin-Chemie Menarini
RandomizedCrossoverOpen-labelOther

Summary

Purpose of the study is to compare three different formulations of Ibuprofen oral suspension (liquid taken by mouth) to see if there are any differences in how much of the active substance and how quickly it was taken up by by the body, broken down, and how quickly it was removed from the body.

Timeline

Start
2023-11-06
Primary completion
2024-04-08
Completion
2025-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 400 mg Oral

Indications

No indication recorded.